WANDERLEY MARQUES BERNARDO
Projetos de Pesquisa
Unidades Organizacionais
FMUSP, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/47 - Laboratório de Hepatologia por Vírus, Hospital das Clínicas, Faculdade de Medicina
LIM/47 - Laboratório de Hepatologia por Vírus, Hospital das Clínicas, Faculdade de Medicina
5 resultados
Resultados de Busca
Agora exibindo 1 - 5 de 5
- Birth route in case of cesarean section in a previous pregnancy(2015) SIMOES, Ricardo; BERNARDO, Wanderley M.; SALOMAO, Antonio J.; BARACAT, Edmund C.
- Is sulfadiazine alone equivalent (benefit and harm) to spiramycin to treat acute toxoplasmosis in the first trimester of pregnancy?(2015) BERNARDO, Wanderley Marques; CHINZON, Miriam; CHAVES, Felipe Galvao Batista
- Prevalence of hepatitis C virus in Brazil's inmate population: a systematic review(2015) MAGRI, Mariana Cavalheiro; IBRAHIM, Karim Yaqub; PINTO, Walkyria Pereira; FRANCA, Francisco Oscar de Siqueira; BERNARDO, Wanderley Marques; TENGAN, Fatima MitikoOBJECTIVE: To estimate the prevalence of hepatitis C virus infection in Brazil's inmate population. METHODS: Systematic review on hepatitis C virus infection in the inmate population. Brazilian studies published from January 1, 1989 to February 20, 2014 were evaluated. The methodological quality of the studies was assessed using a scale of 0 to 8 points. RESULTS: Eleven eligible studies were analyzed and provided data on hepatitis C virus infection among 4,375 inmates from seven states of Brazil, with a mean quality classification of 7.4. The overall hepatitis C virus prevalence among Brazilian inmates was 13.6% (ranging from 1.0% to 41.0%, depending on the study). The chances of inmates being seropositive for hepatitis C virus in the states of Minas Gerais (MG), Sergipe (SE), Mato Grosso do Sul (MS), Rio Grande do Sul (RS), Goias (GO) and Espirito Santo (ES) were 84.0% (95% CI 0.06; 0.45), 92.0% (95% CI 0.04; 0.13), 88.0% (95% CI 0.09; 0.18), 74.0% (95% CI 0.16; 0.42), 84.0% (95% CI 0.08; 0.31) and 89.0% (95% CI 0.01; 0.05) respectively, lower than that observed in the Sao Paulo state (seroprevalence of 29.3%). The four studies conducted in the city of Sao Paulo revealed a lower prevalence in more recent studies compared to older ones. CONCLUSIONS: The highest prevalence of hepatitis C virus infection in Brazil's inmate population was found in Sao Paulo, which may reflect the urban diversity of the country. Despite Brazilian studies having good methodological quality to evaluate the prevalence of the hepatitis C virus, they are scarce and lack data on risk factors associated with this infection, which could support decisions on prevention and implementation of public health policies for Brazilian prisons.
- Endoscopic palliative treatment versus surgical bypass in malignant low bile duct obstruction: A systematic review and meta-analysis(2015) LIMA, Silvia Lucia Alves de; BUSTAMANTE, Fabio Alberto Castillo; MOURA, Eduardo Guimaraes Hourneaux de; BERNARDO, Wanderley Marques; ARTIFON, Everson Luiz de Almeida; CHAVES, Dalton Marques; FRANZINI, Tomazo Antonio Prince; FURUYA JUNIOR, Carlos KiyoshiAims: Despite technological advances, only about 20% of periampullary tumors are found to be resectable at the time of presentation. Biliary tree obstruction and consequent jaundice occur in 70-90% of those patients and has important consequences for a patient's quality of life. Relief of biliary tree obstruction is the main goal for treatment, and few options for palliative therapy of biliary tree obstruction can be performed, including surgical bypass, percutaneous stenting, and endoscopic stenting. Objective: The aim of the present study was to acquire and analyze data to compare the success of procedures, procedure-related complication, mortality in 30 days, recurrent-jaundice rates in endoscopic, and surgical palliative techniques. Methods: Two independent reviewers searched the following electronic databases: Medline, EMBASE, Cochrane, LILACS, BVS, SCOPE, and CINAHL (EBSCO). Inclusion criteria included studies involving patients with distal biliary obstruction due to periampullary tumors who underwent endoscopic therapy or a surgical procedure for palliation. Results: No differences were observed for success of procedures; differences were observed with better outcomes for endoscopy therapy with regards to mortality associated with procedure, complication associated with procedure, and mortality in 30 days. Also, differences were observed with better outcomes for surgery therapy for recurrent-jaundice. Conclusion: Endoscopic palliative drainage is associated with a lower rate in complication, mortality associated with procedure, and mortality in 30 days. Recurrent-jaundice analysis demonstrated an overall lower rate in surgical bypass procedures. No differences were found for the success of procedures.
article 12 Citação(ões) na Scopus Endoscopic-ultrasound versus percutaneous-guided celiac plexus block for chronic pancreatitis pain: A systematic review and meta-analysis(2015) NOBRE MOURA, Renata; HOURNEAUX DE MOURA, Eduardo Guimarães; MARQUES BERNARDO, Wanderley; OTOCH, Jose P; CASTILLO BUSTAMANTE, Fabio Alberto; VIEIRA ALBERS, Débora; RODELA SILVA, Gustavo Luis; MARQUES CHAVES, Dalton; DE ALMEIDA ARTIFON, Everson LuizBackground: Abdominal pain is present in the vast majority of patients with chronic pancreatitis, being frequently debilitating. Celiac plexus block (CPB) is an interventional technique that can be considered to provide a temporary pain relief. Objective: To estimate the effectiveness and safeness of endoscopic-ultrasound (EUS) comparing with percutaneous-guided CBP in patients with pancreatic pain. Methods: A systematic review of English and non-English articles using MEDLINE, EMBASE, LILACS and COCHRANE (via BVS). Study selection and data extraction: Only randomized control trials (RCT) comparing the beneficial and harmful effects of EUS and percutaneous-guided celiac plexus block for managing pancreatic pain were included. Data was extracted and analyzed on variables including pain relief and related procedure complications. Results: Two RCT met the inclusion criteria. Both studies assessed the primary outcome (reduction on pain score) and evaluated adverse effects. The drugs injected were the same; nevertheless percutaneous technique was guided by fluoroscopy in one study and by computer tomography (CT) in other. The results showed that the EUS-CPB group was more effective to reduce pain score after 4 weeks after the procedure, with risk of bias to do this affirmation. No statistical difference in pain relief at 1, 8 and 12 weeks and in complications rates. Conclusions: Based on this systematic review and meta-analysis, no statistically significant difference was noted in pain relief and complications for EUS and percutaneous - CPB.